Sec. 278. ASSESSMENT ON UNITED STATES NATIONAL SECURITY EMERGING BIOTECHNOLOGY EFFORTS AND CAPABILITIES AND COMPARISON WITH ADVERSARIES
357 words·~2 min read·
/statute-compilations/comps-16736/sec-278A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
## SEC. 278 ASSESSMENT ON UNITED STATES NATIONAL SECURITY EMERGING BIOTECHNOLOGY EFFORTS AND CAPABILITIES AND COMPARISON WITH ADVERSARIES ###
(a)Assessment and Comparison Required ####
(1)In general The Secretary of Defense, acting through the Under Secretary of Defense for Research and Engineering and the Under Secretary of Defense for Intelligence and Security, shall conduct an assessment and direct comparison of capabilities in emerging biotechnologies for national security purposes, including applications in material, manufacturing, and health, between the capabilities of the United States and the capabilities of adversaries of the United States. ####
(2)Elements The assessment and comparison carried out under paragraph
(1)shall include the following: #####
(A)An evaluation of the quantity, quality, and progress of United States fundamental and applied research for emerging biotechnology initiatives for national security purposes. #####
(B)An assessment of the resourcing of United States efforts to harness emerging biotechnology capabilities for national security purposes, including the supporting facilities, test infrastructure, and workforce. #####
(C)An intelligence assessment of adversary emerging biotechnology capabilities and research as well as an assessment of adversary intent and willingness to use emerging biotechnologies for national security purposes. #####
(D)An assessment of the analytic and operational subject matter expertise necessary to assess rapidly-evolving foreign military developments in biotechnology, and the current state of the workforce in the intelligence community. #####
(E)Recommendations to improve and accelerate United States capabilities in emerging biotechnologies and the associated intelligence community expertise. #####
(F)Such other matters as the Secretary considers appropriate. ###
(b)Report ####
(1)In general Not later than February 1, 2021, the Secretary shall submit to the congressional defense committees a report on the assessment carried out under subsection (a). ####
(2)Form The report submitted under paragraph
(1)shall be submitted in the following formats— #####
(A)unclassified form, which may include a classified annex; and #####
(B)publically releasable form, representing appropriate information from the report under subparagraph (A). ###
(c)Definition of Intelligence Community In this section, the term “intelligence community” has the meaning given such term in section 3 of the National Security Act of 1947 (50 U.S.C. 3003).
Connectionstraces to 1
Traces to 1 document
U.S. Code
Citation graph
cites case law
Sec. 278
ASSESSMENT ON UNITED STATES NATIONAL SECURITY EMERGING BIOTECHNOLOGY EFFORTS AND CAPABILITIES AND COMPARISON WITH ADVERSARIES
Cites 1Cited by 0 across 0 sources